Biomarkers of acute lung injury: Worth their salt?

BMC Medicine

Volumn 9, Issue , 2011, Pages

  Proudfoot, Alastair G ^a,b   Hind, Matthew ^a,b   Griffiths, Mark J D ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; OXYGEN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD OXYGEN TENSION; CLINICAL ASSESSMENT; FLUID RESUSCITATION; GAS EXCHANGE; HIGH FREQUENCY OSCILLATION; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; LUNG ARTERY PRESSURE; LUNG EDEMA; LUNG FIBROSIS; LUNG LAVAGE; LUNG VENTILATION; MULTIPLE ORGAN FAILURE; PATHOGENESIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERMODILUTION; THORAX RADIOGRAPHY; TIDAL VOLUME; BIOLOGICAL MODEL; BLOOD; METABOLISM; REPRODUCIBILITY; TRANSLATIONAL RESEARCH;

ACUTE LUNG INJURY; BIOLOGICAL MARKERS; HUMANS; MODELS, BIOLOGICAL; OXYGEN; PULMONARY EDEMA; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; RESPIRATORY DISTRESS SYNDROME, ADULT; TRANSLATIONAL MEDICAL RESEARCH;

EID: 83155163765     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-9-132     Document Type: Article

References (67)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693. 10.1056/NEJMoa050333, 16236739.
3. Cheung AM, Tansey CM, Tomlinson G, Diaz-Granados N, Matte A, Barr A, Mehta S, Mazer CD, Guest CB, Stewart TE, Al-Saidi F, Cooper AB, Cook D, Slutsky AS, Herridge MS. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 2006, 174:538-544. 10.1164/rccm.200505-693OC, 16763220.
4. Proudfoot AG, McAuley DF, Hind M, Griffiths MJ. Translational research: what does it mean, what has it delivered and what might it deliver?. Curr Opin Crit Care 2011, 17:495-503. 10.1097/MCC.0b013e32834a4b19, 21825976.
5. Cross LJ, Matthay MA. Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury. Crit Care Clin 2011, 27:355-377. 10.1016/j.ccc.2010.12.005, 21440206.
6. Frank JA, Parsons PE, Matthay MA. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 2006, 130:1906-1914. 10.1378/chest.130.6.1906, 2764530, 17167015.
7. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991, 88:1976-1981. 10.1172/JCI115523, 295781, 1752956.
8. Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979, 120:1039-1052.
9. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay MA. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002, 346:1281-1286. 10.1056/NEJMoa012835, 11973365.
10. Christie JD, Ma SF, Aplenc R, Li M, Lanken PN, Shah CV, Fuchs B, Albelda SM, Flores C, Garcia JG. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma. Crit Care Med 2008, 36:2794-2800. 10.1097/CCM.0b013e318186b843, 18828194.
11. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002, 166:646-650. 10.1164/rccm.2108086, 12204859.
12. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996, 275:50-54. 10.1001/jama.1996.03530250054027, 8531287.
13. Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, Hudson LD, Parsons PE. Diabetic patients have a decreased incidence of acute respiratory distress syndrome [see comments]. Crit Care Med 2000, 28:2187-2192.
14. Rocco PR, Zin WA. Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different?. Curr Opin Crit Care 2005, 11:10-17. 10.1097/00075198-200502000-00003, 15659940.
15. Martin C, Papazian L, Payan MJ, Saux P, Gouin F. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients [see comments]. Chest 1995, 107:196-200. 10.1378/chest.107.1.196, 7813276.
16. Dos Santos CC. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med 2008, 34:619-630. 10.1007/s00134-007-0963-x, 18264692.
17. Pratt PC, Vollmer RT, Shelburne JD, Crapo JD. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am J Pathol 1979, 95:191-214. 2042296, 434109.
18. Chesnutt AN, Matthay MA, Tibayan FA, Clark JG. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997, 156:840-845.
19. Owens CM, Evans TW, Keogh BF, Hansell DM. Computed tomography in established adult respiratory distress syndrome. Correlation with lung injury score. Chest 1994, 106:1815-1821. 10.1378/chest.106.6.1815, 7988207.
20. Quesnel C, Nardelli L, Piednoir P, Lecon V, Marchal-Somme J, Lasocki S, Bouadma L, Philip I, Soler P, Crestani B, Dehoux M. Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance. Eur Respir J 2010, 35:1312-1321. 10.1183/09031936.00074709, 19840966.
21. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 2000, 97:1778-1783. 10.1073/pnas.97.4.1778, 26512, 10677534.
22. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010, 298:L715-731. 10.1152/ajplung.00361.2009, 2886606, 20363851.
23. Network TARDS Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308. Network TARDS.
24. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575.
25. McAuley DF, O'Kane C, Griffiths MJ. A stepwise approach to justify phase III randomized clinical trials and enhance the likelihood of a positive result. Crit Care Med 2010, 38:S523-527.
26. Determann RM, Royakkers A, Wolthuis EK, Vlaar AP, Choi G, Paulus F, Hofstra JJ, de Graaff MJ, Korevaar JC, Schultz MJ. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care 2010, 14:R1. 10.1186/cc8230, 2875503, 20055989.
27. Villar J, Slutsky AS. Is acute respiratory distress syndrome an iatrogenic disease?. Crit Care 2010, 14:120. 10.1186/cc8842, 2875513, 20236490.
28. Yilmaz M, Keegan MT, Iscimen R, Afessa B, Buck CF, Hubmayr RD, Gajic O. Toward the prevention of acute lung injury: protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007, 35:1660-1666. quiz 1667, 10.1097/01.CCM.0000269037.66955.F0, 17507824.
29. Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, Hubmayr RD, Gajic O. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007, 131:1308-1314. 10.1378/chest.06-3048, 17400669.
30. Li G, Malinchoc M, Cartin-Ceba R, Venkata CV, Kor DJ, Peters SG, Hubmayr RD, Gajic O. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011, 183:59-66. 10.1164/rccm.201003-0436OC, 20693377.
31. Young MP, Manning HL, Wilson DL, Mette SA, Riker RR, Leiter JC, Liu SK, Bates JT, Parsons PE. Ventilation of patients with acute lung injury and acute respiratory distress syndrome: has new evidence changed clinical practice?. Crit Care Med 2004, 32:1260-1265. 10.1097/01.CCM.0000127784.54727.56, 15187503.
32. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Regnier B, Brun-Buisson C, Chastre J, Wolff M. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474. 10.1016/S0140-6736(09)61879-1, 20097417.
33. Karlsson S, Heikkinen M, Pettila V, Alila S, Vaisanen S, Pulkki K, Kolho E, Ruokonen E. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010, 14:R205. 10.1186/cc9327, 3219988, 21078153.
34. Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, Cohen Y. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004, 32:1166-1169. 10.1097/01.CCM.0000126263.00551.06, 15190968.
35. Luyt CE, Combes A, Trouillet JL, Chastre J. Value of the serum procalcitonin level to guide antimicrobial therapy for patients with ventilator-associated pneumonia. Semin Respir Crit Care Med 2011, 32:181-187. 10.1055/s-0031-1275530, 21506054.
36. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173:281-287. 10.1164/rccm.200508-1302OC, 16254268.
37. Sakka SG, Klein M, Reinhart K, Meier-Hellmann A. Prognostic value of extravascular lung water in critically ill patients. Chest 2002, 122:2080-2086. 10.1378/chest.122.6.2080, 12475851.
38. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, McLaughlin B, Elborn JS, McAuley DF. Extravascular lung water indexed to predicted body weight is a novel predictor of intensive care unit mortality in patients with acute lung injury. Crit Care Med 2010, 38:114-120. 10.1097/CCM.0b013e3181b43050, 19789451.
39. Phillips CR, Chesnutt MS, Smith SM. Extravascular lung water in sepsis-associated acute respiratory distress syndrome: indexing with predicted body weight improves correlation with severity of illness and survival. Crit Care Med 2008, 36:69-73. 10.1097/01.CCM.0000295314.01232.BE, 18090369.
40. Estenssoro E, Dubin A, Laffaire E, Canales H, Saenz G, Moseinco M, Pozo M, Gomez A, Baredes N, Jannello G, Osatnik J. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 2002, 30:2450-2456. 10.1097/00003246-200211000-00008, 12441753.
41. Cooke CR, Shah CV, Gallop R, Bellamy S, Ancukiewicz M, Eisner MD, Lanken PN, Localio AR, Christie JD. A simple clinical predictive index for objective estimates of mortality in acute lung injury. Crit Care Med 2009, 37:1913-1920. 10.1097/CCM.0b013e3181a009b4, 2731230, 19384214.
42. Cooke CR, Kahn JM, Caldwell E, Okamoto VN, Heckbert SR, Hudson LD, Rubenfeld GD. Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med 2008, 36:1412-1420. 10.1097/CCM.0b013e318170a375, 18434894.
43. Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA 1999, 282:771-778. 10.1001/jama.282.8.771, 10463714.
44. Parsons PE, Matthay MA, Ware LB, Eisner MD. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005, 288:L426-431. 10.1152/ajplung.00302.2004, 15516488.
45. Calfee CS, Eisner MD, Parsons PE, Thompson BT, Conner ER, Matthay MA, Ware LB. Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med 2009, 35:248-257. 10.1007/s00134-008-1235-0, 2790376, 18670758.
46. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005, 33:1-6. discussion 230-232.
47. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA, . NHLBI ARDS Network Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax 2008, 63:1083-1089. 10.1136/thx.2008.095588, 2764528, 18566109, NHLBI ARDS Network.
48. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003, 58:983-988. 10.1136/thorax.58.11.983, 1746524, 14586055.
49. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007, 35:1821-1828. 10.1097/01.CCM.0000221922.08878.49, 2764536, 17667242.
50. Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 1998, 110:482-488.
51. Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, Thompson BT, Matthay MA, . National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 2011, 39:711-717. 10.1097/CCM.0b013e318207ec3c, 21283009, National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network.
52. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010, 137:288-296. 10.1378/chest.09-1484, 2816641, 19858233.
53. Proudfoot AG, McAuley DF, Griffiths MJ, Hind M. Human models of acute lung injury. Dis Model Mech 2011, 4:145-153. 10.1242/dmm.006213, 3046086, 21357760.
54. Bastarache JA, Blackwell TS. Development of animal models for the acute respiratory distress syndrome. Dis Model Mech 2009, 2:218-223. 10.1242/dmm.001677, 2675821, 19407329.
55. Gharib SA, Nguyen E, Altemeier WA, Shaffer SA, Doneanu CE, Goodlett DR, Schnapp LM. Of mice and men: comparative proteomics of bronchoalveolar fluid. Eur Respir J 2010, 35:1388-1395. 10.1183/09031936.00089409, 3049194, 20032019.
56. Bastin AJ, Sato H, Davidson SJ, Quinlan GJ, Griffiths MJ. Biomarkers of lung injury after one-lung ventilation for lung resection. Respirology 2011, 16:138-145. 10.1111/j.1440-1843.2010.01870.x, 20920144.
57. Moloney ED, Griffiths MJ. Protective ventilation of patients with acute respiratory distress syndrome. Br J Anaesth 2004, 92:261-270. 10.1093/bja/aeh031, 14722180.
58. van der Werff YD, van der Houwen HK, Heijmans PJ, Duurkens VA, Leusink HA, van Heesewijk HP, de Boer A. Postpneumonectomy pulmonary edema. A retrospective analysis of incidence and possible risk factors. Chest 1997, 111:1278-1284. 10.1378/chest.111.5.1278, 9149583.
59. Licker M, Diaper J, Villiger Y, Spiliopoulos A, Licker V, Robert J, Tschopp JM. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care 2009, 13:R41. 10.1186/cc7762, 2689485, 19317902.
60. Schilling T, Kozian A, Huth C, Buhling F, Kretzschmar M, Welte T, Hachenberg T. The pulmonary immune effects of mechanical ventilation in patients undergoing thoracic surgery. Anesth Analg 2005, 101:957-965. 10.1213/01.ane.0000172112.02902.77, 16192502.
61. Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, Hall J, Israel E, Jain M, Needham DM, Randolph AG, Rubenfeld GD, Schoenfeld D, Thompson BT, Ware LB, Young D, Harabin AL. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2010, 181:1121-1127. 10.1164/rccm.201001-0024WS, 2874454, 20224063.
62. Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, Gandini G, Herrmann P, Mascia L, Quintel M, Slutsky AS, Gattinoni L, Ranieri VM. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2007, 175:160-166.
63. Terragni PP, Del Sorbo L, Mascia L, Urbino R, Martin EL, Birocco A, Faggiano C, Quintel M, Gattinoni L, Ranieri VM. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 2009, 111:826-835. 10.1097/ALN.0b013e3181b764d2, 19741487.
64. Munger JS, Harpel JG, Giancotti FG, Rifkin DB. Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell 1998, 9:2627-2638. 25536, 9725916.
65. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LA, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001, 107:1537-1544. 10.1172/JCI11963, 200192, 11413161.
66. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995, 122:17-23.
67. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139. 10.1056/NEJMoa040938, 15118073.